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1. Introduction 
The main parts of osteoporosis clinics are BMD (Bone Mineral Densitometry) centers. For 
increasing our knowledge about osteoporosis we have to increase our knowledge about 
BMD (Bone Mineral Density), and increasing the knowledge about BMD has a close 
relationship with realizing the principles and appliances of BMD machines and DXA 
method. For specific development in a BMD department, we need to know some historical, 
technical and practical points about these method and machines. In this review, the last 
developments in this field are suggested, also.  
2. General information about BMD and BMD centres 
2.1 What we do in a BMD centre? 
1. Determine patient’s BMD  
2. Estimate the risk of fracture (pathologic fracture) in a patient  
2.2 Some historical points about dual X-ray absorptiometry 
It is very useful to know the history of BMD and DXA devices. The first marketing of this 
machine was in 1987 and in1994 this method described as gold standard for osteoporosis 
diagnosis by World Health Organisation (WHO). It means osteoporosis disease, as we know 
now, was described in 1994 for the first time.(Lukaski, 1993; Kanis, 1994).  
2.3 Distribution of BMD devices around the world 
As Kanis and Johnel reported in 2005, 9 countries from 20 countries (in Europe), had more 
than 10 DXA units per million of the population (the European standard). However it is 
unclear which percent of machines were dedicated in part or in full to clinical research. They 
conclude that the majority of countries are under-resourced. Inequity of geographical 
location, is an important problem, which is a known problem in Italy, Spain, Switzerland 
and the UK. (Kanis & Johnell,2005). However the distribution and utilization of these 
machines are increasing worldwide. This statistics seems interesting when you know there 
was almost 183 machines in Canada in 1998, and there was no such device in Prince Edward 
Island (of Canada) around 1998. In Canada there are almost 600 devices, nowadays. The 
European standard is 0.11 DXA machine per 10 000 population (Mithal et al., 2009).  
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Asian audit in 2009, show us a very different picture in Asia. DXA technology is relatively 
expensive and is not widely available in most developing Asian countries, especially in rural 
areas. There was only 450 DXA machines in China for a population of 1.3 billion. In Srilanka 
only 4 machines exist. (Mithal et al., 2009). In 2008, Indonesia had a total of only 34 DXA 
machines, half of them in Jakarta, for a population of 237 million (0.001 per 10,000 
population)(IOF, 2011). One of the most extreme examples is found in India, reportedly, 
there was only approximately 100 DXA units, located in six cities. This inequity results in 
long waiting times or long distances to travel or in many cases, no access (Kanis & 
Johnell,2005) (Fig. 1. And Fig. 2.). With above examples about distribution of these machines 
around the world, we explain here the formula used for calculating standard requirement of 
these machines (this formula is calculated according to number of population and 
prevalence of risk factors in target population). 
 
 
 
Fig. 1. Density (number /million of the population) of central DXA (spine/hip) units in 
different European countries in 2003 (from Kanis and Johnell, 2005). 
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Fig. 2. Density (number /million of the population) of central DXA (spine/hip) units in non-
European countries in 2003 (from Kanis and Johnell, 2005). 
2.4 Requirement for DXA 
Kanis and Johnel, extensively explained the method used for estimation of required number 
of DXA machines in Europe. As the method is interesting and contained demographic and 
osteoporotic statistics in Europe, we repeat their explanation as extensive as is used in their 
article in 2005. Repeat the explanation may be helpful, clearing a guideline for clinicians and 
researchers, to calculate the requirement of DXA machines in their area or countries. They 
suggested the requirement for three scenario and in two category, requirements of DXA for 
risk assessment and requirements of DXA to monitor treatment. 
2.4.1 Requirements of DXA for risk assessment 
From total population of Europe, it is estimated that, 4 million of them were  65 years old 
women. The authors assumed that individuals over the 65 years would be tested over the 
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ensuing 10 years and repeated BMD tests would perform in patient that need treatment or 
those patients at high risk on the basis of the screening BMD test. 
The first scenario (scenario A or screening women with BMD), proposed monitor all women 
with at the age of 65 years. If the main goal was to measure BMD in all 65 years old women 
(4.045.000, 65 years old women), this required 3231 DXA units or 4.42 DXA/ million of the 
total population. In this first scenario, if we assumed that people with the age 66 years and 
older didn’t screen and if they want to screen over a 10- year period, the needs for DXA 
units would be 6.79/million of total population, giving a total need 11.2 units/million.  
The aim of second scenario (scenario B, or clinical case finding with selective use of BMD) 
was to screen 65 years old women with clinical risk factor referred for DXA at 10 yearly 
intervals. It means that we sent 65 y/o women for BMD, only when they were high risk for 
fracture. Finding patients at high risk was based on clinical risk factors. Patients were high 
risk, when 10-year probability of hip fracture in them (calculated upon risk factors), was 4% 
and more (This is also called intervention threshold, and the authors considered it a cut-off 
that treatment is needed for patients). Screening all these patients, need 767 DXA units or 
1,05 scan/million of the population. No surprising, the population that need intervention 
and treatment advances with age. The probability of risk fracture is about 1% at the age of 
50 and 52% at the age of 80 years old. Author emphasize that the absolute population size 
decreases the higher the starting age for testing. They calculated that assessment of women 
at the older age, (during 10 years period) would require an extra need of 2301 DXA units or 
3.16/million of the population (total need for women 65 y/o and older equals to 
4.21/million). At younger age, small population is selected for BMD test. So the 
requirements are not markedly differ by screening policy that starts at age of 50 years. At 
this age, only nearly 1% of women are selected for treatment. It would be required that more 
50,000 DXA tests do for 50 years old women (that add 40 scanning units or 0.05 
units/million machines to requirement). After added screened population aged more than 
50 years over a 10 year term interval, the total requirement will be 4.5 unit/million. 
Compare it with 4.21 unit/million required only for screening of 65 y/o women and older.  
The third scenario (scenario C, or classic case finding strategy) enlisted only women with 
strong risk factors for fracture, to do BMD. The authors suggested a different prevalence of 
risk factors in different age population (29% to 46% depending on age). For testing women 
of 65 years, 1481 units or 2.03 units/million of the population was required. If BMD 
considered in women aged more than 65 years and a risk factors prevalence as 46%, 3 
million/year over a 10 year interval (30 million, for 10 years) would require testing . This is 
equal to 3.33 units/million of the population. On the other hand, if BMD tests considered for 
women aged 50 years or more with one or more these risk factors, BMD testing was needed 
in 36.9% of the female population aged 50 years or more. Authors calculated this would 
need 3842 scanning units or 5.3/million of the total population (It seems it is a yearly need, 
when the whole 10 year need is divided by 10). When only women with incident 
osteoporotic fracture and aged 65 years or older sent to BMD centers, requirement was 918 
scanning visits or 1.3/million of the general population. 
2.4.2 Requirements of DXA to monitor treatment 
When women referred for treatment, 2 BMD tests may be required. One is at the time of 
diagnosis, and a second at an interval of 2 years. For scenario B, BMD tests would have been 
done in 24% of the population at the age of 65 years, some of them do not need treatment 
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and so don’t need a further BMD test in the beginning of treatment (they did’t cut the 
threshold for need to intervention). Additional BMD testing would be required in 
approximately 10% of women for the purposes of baseline investigation for treatment. If all 
65-year-olds were screened, additional pre-treatment BMD tests would equal to 0.4/million 
scans (322 units) and approximately increase 2-fold after 2 years later. Thus, the steady state 
requirements would be 966 scanners or 1.33 units/million of the population. Women older 
than 65 years have a smaller population , but not surprisingly ,a larger proportion would cut 
an intervention threshold. For example, at the age of 80 years there are approximately 2.15 
million women, but with the same test, 73% would be need treatment. But in  50 years old 
women, approximately 1% of their 5 million population would need treatment. The author 
emphasized that in women aged 65 years or more, approximately 35% will need treatment 
and require a BMD tests before and after treatment  (2 years later). This gives an annual 
requirement for 4.6 million scans or 3686 scanning units and a requirement of 5.06/million 
of the general population. It means for the monitoring of treatment (in 65 y/o women and 
older), 6.39 uint/million is needed under scenario B.  All of these, means the total number 
10.6 scanning units/million of the population is needed for assessment plus monitoring of 
treatment in scenario B (Kanis & Johnell,2005).  
2.5 Secular trend of use of DXA 
The total number of all older patients performed DXA in the USA has grown up from 501,105 
in 1996 to 2,195,548 in 2002. This 4 fold growth during 6 years related to increase the average of 
lifespan, increase public awareness of osteoporosis and development in therapeutic cares. The 
maximum application of DXA has been observed in central densitometry. The usage of this 
method maybe continued for the next few years. However, in some countries, DXA just 
applied for patients with certain ( or specific ) risk factors. There are national organization in 
other countries that prescribe DXA only for patients at multiple risks of osteoporosis. It cause 
different  statistics of use of DXA in different countries (Damilakis et al., 2010). 
Results show a great increase in use of bone mass densitometry in Canada. DXA-BMD 
tests increase 10-fold between years 1993 to 2005, and approximately 500,000 scans 
perform per year. In Ontario, showed an excessive use of anti-osteoporotic drugs along 
with the reduction rate of hip and wrist fractures with the increase in BMD test.The 
growth rate of BMD test appeared to be decreased to 6 to 7% per year. The increase usage 
rate of BMD-test occurred mainly in 65 years old people or older (Legislative Assembly of 
Ontario, 2006). 
3. Bone densitometry instruments 
3.1 Instruments 
Lukaski, had a good review of instruments in dual x-ray absorptiometry. Because of  its 
clear and good explanation about the complexity of matter, we mension it here, with almost 
no change. The first generation commercial dual-energy X-ray absorptiometry (DXA) 
system became available in 1987 after its initial progress in the late 1960s and 1970s. The 
three main companies, introduced three X-ray-based absorptiometry systems (approved by 
the Food and Drug Administration): QDR-1000W3 (Hologic Inc., Waltham, MA), DPX 
(Lunar Radiation Corp., Madison, WI) and XR-26 (Norland Corporation, Fort Atkinson, WI). 
Each system uses a source- that generates X-rays at two different energies- a detector and an 
interface with a computer system. 
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These three DXA systems operate in different ways. The QDR-1000 and QDR- 1000W 
systems produce two X-ray beams of different energies by using an X-ray tube alternately 
pulsed at 70 and 140 kVp peaks. The DPX system uses a constant potential generator and 
a Cerium K-edge X-ray filtration to generate photons at two energies (40 and 76 keV). The 
Norland XR-26 unit also employs a constant potential X-ray generator, but it operates at 
100 kVp and employs a Samarium filter (K-edge = 46.8 keV). Unlike the DPX and XR-26 
systems, the QDR-1000W system has an internal calibration system that consists of a 
rotating filter wheel composed of three sections (two sections of epoxy-resin-based 
material consistent with the densities of bone and soft tissue and one section of air). In the 
QDR system, photons of only one energy are present at any one time, and the detector 
measures the intensity of the transmitted photons without energy discrimination. An 
integral line single detector is used in the Lunar DPX system. The XR-26 detector consists 
of thin and thick sodium iodide crystals (low intensity X rays are stopped by the thin 
crystal, and high intensity photons are trans mitted and detected by the second thick 
crystal). 
An important advantage of the DXA systems is the increased photon flux emanating from 
the X-ray sources in comparison to the photon flux from the radioisotope source used in 
dual-photon absorptiometry. The increased photon flux improves the resolution and 
precision of the image and reduces the time for a scan. To assess soft tissue composition, the 
DXA systems use different forms of external calibration. The QDR and XR-26 systems rely 
on external standards, which are wedges made of aluminum and  ucite 
(polymethylmethacrylate) calibrated against stearic acid as 100% fat, and dilute saline 
solution as 100% fat-free mineral free tissue. The DPX systems use a plastic 
polyoxymethylene (Delrin), as 40% fat equivalent and water (~5% fat) as standards 
(Lukaski, 1993). Recently, the name of Medi-link brand is added to list of machines in FRAX 
software. Fan beam models are added to DXA machines family and have different beam 
geometry from pencil beam models. They are explained later. 
BMD devices are popular machines, because they are low X-ray radiating, don’t need 
especial preparation for patients and they are not invasive but as it mentioned before, these 
instruments are not widely distributed in the world, and the expensive cost of these 
machines is a main reason for it. Properties of these devises that make them expensive are: 
 Safety 
 The Hardware 
 The Software 
3.2 Safety 
The special method used in these devices, make them low X-ray radiating. They don’t need 
special shielding. We can evaluate the safety of DXA by the radiation dose that each patients 
or subjects receive. The  average skin dose is 1-3 mrad per scan. The radiation dose of DXA 
is less than other radiologic methods, such as single-photon absorptiometry, dualphoton 
absorptiometry and quantitative digital radiography, conventional chest x-ray and many 
others. For example, skin exposures from environmental background are ~3.5 mrad/wk; 
from dental bite-wing posterior films, 334 mrad and from chest X-ray films, ~8-10 mrad. 
Thus, we can conclude; for routine measurement of human body composition and bone 
mineral status , DXA may be noticed a relatively safe method. Manufacturers suggest that it 
is safe from 1 meter (Lukaski, 1993).   
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3.2.1 Dose reduction techniques for patients 
Damilakis et al, remind us that the system for patients protection against radiation is based 
on 2 principles: (a) justification and (b) optimisation. Clinically justification of all X- ray 
exposures used for bone densitometry is very important. Examinations that do not influence 
patient care, must be avoided. 
Preparing patients before bone densitometry is very important. For example metallic things 
such as jewelry or coins can cause artifact and careful checking for the presence of these 
items and proper positioning of patient before bone densitometry, will optimize the imaging 
quality and there will be no need to repeat imaging with additional radiation exposure. In 
pediatric examinations, proper interaction with the children and parents is essential. All 
actions should be taken to avoid movement of the child during imaging and to avoid 
repeating measurement. The duration time of DXA should be minimize and should take 
into account patient’s body size, if possible (Damilakis et al., 2010). 
3.2.2 Occupational radiation doses and shielding 
Although the annual occupational doses from DXA is very lower than standard 
occupational radiation dose, but for a pregnant employee that declares pregnancy, special 
dose reduction should be applied. As Damilakis et al. suggest, The ICRP and European 
Commission recommend that pregnant individual be protected by the application of a dose 
up to 1 mGy. Of course, as they emphasize, the exclusion of pregnant workers from DXA 
examinations on the basis of radiogenic risks from occupational DXA exposure cannot be 
justified on scientific grounds. Because the scatter radiation can increase the exposure limits 
for pregnant workers, especially for fan-beam systems. Radiation protection measures 
should always be taken to ensure that the conceptus dose will be kept below 1 mGy during 
the declared pregnancy. For monitoring radiation dose, it is recommended to use personal 
radiation meter at waist level.   
Correcting design of the room in which the imaging device has been installed, can influence 
in limiting the risk of radiation exposure in the workplace. Measurements performed by 
Larkin et al. as cited in Damilakis et al., 2010, showed that the scatter from fan-beam DXA 
systems can increase the limits for public exposure i.e. 1 mSv/year. In these cases, additional 
structural shielding might be required, especially when the distance from the imaging table 
to the adjacent wall is less than 1 m. They say, parameters like the workload, the material of 
the walls, the location of the operator and the location and use of rooms that adjoin the 
imaging room must also be remembered as important factors (Damilakis et al., 2010). 
3.3 Hardware 
3.3.1 Basic principles of dual-energy X-ray absorptiometry (DXA) 
The proportion of beam of X- rays weaken (attenuating) during transporting through a 
complex material depend on composition of material, the thickness of material and any of 
its components. Soft tissues, which contain principally water and organic compounds create 
limitation to the flux (number of X-rays per unit area) of X-rays, and of course, this 
limitation is lesser than the limitation creates by bone tissue. The un-weakened or un-
attenuated energy, in the form of X-ray radiation, is detected by an external detector. In 
dual-energy X-ray system, there is a source that emits X-rays, which are collimated into a 
beam (there is a shutter that can turn on and turn off the beam, also). The source lies beneath 
the patient and the beam transports in a posterior-to-anterior direction, through the body of 
patient (bone and soft tissue), and goes upward to be detected by a detector, above the 
patient, lies in the arm of machine (Lukaski, 1993).   
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3.3.2 Specific technology of dual energy X-ray absorptiometers scanners (DXA) 
Before using dual x-ray absorptometry (when single-photon or single-x-ray absorptiometry 
used), the ROI (region of interest) of scanning, should be immersed in a water bath for 
densitometry (Fig. 3.). By use of water bath, the water and soft tissue (with almost the same 
attenuation), make a single compartment of attenuation (on the other hand, the influence of 
soft-tissue in the measurement significantly reduces and soft tissue don’t contributed to 
measured absorption). They make one compartment and bone makes another compartment 
with its specific attenuation (than is very different and very higher that other compartment). 
This can lead to calculating of density of bone, because the attenuation of energy of x-ray 
beam is related to density of tissue. The density of soft-tissue (and water) is known and 
constant in almost all humans. The density of bone is not constant and changes one by one. 
By comparing the attenuation of energy of bone compartment of anyone to attenuation of 
energy of his soft tissue, machine can calculate the bone density. Without water bath, there 
is 3 compartment (air, soft tissue and bone), that machine can’t separate them exactly and so 
can’t differ between their density, and there is not single reference for comparing density of 
bone. So finding the exact density of bone would be impossible. Using of water-bath was a 
development for bone densitometry.  But some big practical problems remained. It is 
practically, impossible to immerse whole body in water bath to measure the bone density of 
e.g. Spinal region or neck of femur. Water bath was useful for testing BMD of forearm. 
Remember spine and femur are most important parts of densitometry, because the 
important or fatal pathologic fracture occurs in these regions and measuring the BMD of e.g. 
forearm is not a good predictor of BMD or fracture in these important parts. The creating 
DXA methods, came helpful in solving this big problem. Imagine, using Dual x-ray 
absorptiometry (using 2 different energy beams) works as water bath in creating two 
distinguished compartment from compartments that were previously three different 
compartments of  air, soft tissue and bone. The DXA (Dual X-ray absorptiometry) method 
depends on the differential absorption of two distinct beam energies - a high and low 
energy beam. When measuring bone, bone will normally have air and soft tissue around it. 
The high and low energy photons don’t change in soft tissue, but the lower energy photon 
will be significantly reduced by bone tissue (high energy photon don’t changes 
significantly). This difference in reduction of low energy beam, in two different tissue-bone 
and soft-tissue- can be used for measurement of bone density. On the other hand, the soft 
tissue component becomes the reference for determining the bone component (Royal 
Adelaide Hospital, 2009). When two different beams, pass from body compartments, the 
difference between their intensity before and after passing the soft tissue (and air), don’t 
change (so, the air and soft tissue around the bone create a single compartment). This 
constant difference can be considered as 1 unit of difference. When two different beams, 
pass from bone tissue, the low energy beam attenuates significantly after passing bone, it 
means there is big difference in the intensity of low energy beam before and after passing 
bone. So the difference between intensity of two high and low energy beams increase 
significantly and may be multiple times of 1 unit difference reported for soft tissue (and air). 
This increase in difference is a result of attenuation of low beam energy in bone tissue and 
relates to bone density. If we have the density of soft tissue compartment, now we can 
calculate the density of bone. As mentioned before, the density of soft tissue is known and 
constant and is used as reference for determining bone density in DXA method. It means 
use of DXA, makes bone densitometry possible, without need to water bath that was needed 
in single x-ray absorptiomtery. Dual x-ray absorptiometry, makes axial bone densitometry 
in the conventional form that is performing now, possible (with patient lying on a table in 
normal atmosphere of an imaging room with no special preparation).  
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Fig. 3. Different methods of bone densitometry 
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3.3.3 Quality control 
For diagnosing longitudinal changes, assessment of precision error in bone mineral density 
(BMD) testing is very important (Leslie et al., 2007).  Lukaski emphasizes that one parameter 
of quality control in the use of DXA is the precision of the measurements. Precision is 
generally reported as the coefficient of variation (CV), which is the standard deviation of 
repeated measurements expressed as a percentage of the mean of the measurements. The 
precision of DXA has been assessed for short-term (in vitro and in vivo) and for long-term 
(in vitro) (Lukaski, 1993). 
The International Society for Clinical Densitometry (ISCD) has a standardized methodology 
for performing an in vivo precision study and recommends that this be performed by each 
densitometry center. Leslie at al., explain the ISCD procedure as  gaining precision error 
from an assessment with 30 degrees of freedom (df; e.g., 30 subjecs with 2 scans each or 15 
subjects with 3 scans each) drawn from the patient of referral population and using the root 
mean square (RMS) approach (RMS is not explained there) (Leslie et al., 2007). 
Lukaski, reports that in first studies, short-term precision and long-term Precision,  in 
different period times and different devices studied. Wahner et al. (1988), as cited in 
Lukaski; 1993, reported a short-term precision (repeat measurements on the same day) of 0.2 
and 0.5% for BMC and BMD, respectively, and a long-term precision (for up to 6 mo) of 
0.4% for BMD in lumbar spine phantoms made of hydroxyapatite. Duplicate scans 
performed on the same day in patients showed a difference of <1% between scans for BMC 
and BMD. Kelly et al. (1988), as cited in Lukaski; 1993,  also observed high reproducibility 
(CV = 0.23%) of BMD measurements in spine phantoms measured over 6 months. Rencken 
et al. (1991), as cited in Lukaski; 1993, evaluated the precision of DXA measurements using 
six different QDR instruments at separate locations. Nine consecutive scans were performed 
on a single spine phantom at each site. The investigators reported an average precision for 
BMC and BMD of <1% (range: 0.3-0.6%). The average of the highest and lowest mean values 
was 1.1% for BMC and 1.07% for BMD. Mazess et al. (1989), as cited in Lukaski; 1993, 
reported a long-term precision in BMD measurements of 0.6% using a DPX system in a 
spine phantom over 6 mo. Estimates of 1.8 and 0.9% for the measurement of total body BMC 
and BMD, respectively, in 12 adults were also reported with a DPX instrument (Mazess et al. 
1990, as cited in Lukaski; 1993). Johnson and Dawson-Hughes (1991), as cited in Lukaski; 
1993, assessed long-term precision of BMD measurements in six volunteers scanned six 
times initially and at the same frequency 9 mo later. The short-term precision of BMD 
measurements in the spine, femoral neck and whole body were 1.08, 2.08 and 0.66%, 
respectively. The long-term precision was 1.01, 2.07 and 0.62%, respectively. The 
investigators also reported the precision in determining body composition variables;  thus, 
the precision of whole-body BMC, fat-free mass and fat mass was 0.8, 1.1 and 2.7%, at the 
start of the study, and 1.2, 1.0, and 1.7%, respectively, after 9 months.  
Another aspect of quality control is the accuracy of the DXA measurement. The extent to 
which DXA measurements represent true bone mineral status has been assessed by 
measuring the mineral content of cadaver vertebrae of known ash weights and volumes. Ho 
et al. (1990), as cited in Lukaski; 1993, measured BMC and BMD in lumbar vertebrae from 11 
cadavers. The ash weights of 31 lumbar vertebrae and the DXA BMC values were 
significantly correlated (r = 0.963, SEE = 1.01 g; P< 0.001 ). The slope of the regression of ash 
weight as the dependent variable versus QDR-BMC as the independent variable was 1.0, but 
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the intercept was 0.59. Although the value of 0.59 was not statistically different from 0, the 
authors concluded that DXA under estimates ash weight (Lukaski, 1993). 
Before to 2000, DXA measurements were conducted with a pencil-beam instrument (Lunar 
DPX, GE Lunar, Madison WI), and after that a fan-beam instrument was used. As Leslie et al 
suggested in 2011, instruments were cross-calibrated using anthropomorphic phantoms and 
59 volunteers. They say there was no clinically significant differences (T-score differences 
<0.2). Densitometers showed stable long-term performance [CV<0.5%] and satisfactory in 
vivo precision (CV 1.7% for L1–4 and 1.1% for the total hip) (Leslie et al., 2011) 
3.3.4 The long-term performance of DXA bone densitometers 
Monitoring the performance of DXA after long time utilization is very important because 
any deterioration could change bone mineral density (BMD) measurements and affect 
clinical management. The importance of DXA in longitudinal trials of new osteoporosis 
therapies also need constant  performance over years to confirm that any altration in bone 
density is real and not due to machine shifts or fluctuation. In this way, Wells and Ryan, 
assessed the performance of a 6-year-old bone densitometer (a Lunar DPX alpha), which has 
undertaken 1500 scans/year over this period. They concluded that the machine performs 
extremely well over a long period and after 6 years of Performing, measurements is very 
suitable to be fit for clinical use. It may be can be generalized to all main DXA devices in 
market  (Wells & Ryan, 2000). 
3.3.5 Beam geometry  
At website of department of nuclear medicine, PET & bone densitometry of Royal Adelaide 
Hospital (Australia), at section of “Bone Densitometry Equipment”, beam geometry of 
“DXA devices” are explained so: 
3.3.5.1 Pencil beam  
First generation bone densitometers (isotope and x-ray) use this beam geometry. The photon 
beam is tightly collimated with one photon source and one detector (some scanners have 
two, usually photomultiplier tubes). The source and detector are rigidly coupled and moved 
together in a rectilinear manner to build an image of the bone being examined line by line. 
The disadvantage of this technology is the relatively slow scan speed (typically 2-4 minutes 
per scan site). However, the direct relationship between source and detector means that 
calculated bone and tissue masses are less likely to be artefactual. 
3.3.5.2 Fan beam  
The second generation of x-ray bone densitometer has a fan geometry, with a source which 
fans out in the short axis plane of the patient and is measured by an array of detectors in the 
same plane.  
The bones are imaged in one pass along the long axis of the body (as illustrated at middle) 
providing an immediate advantage in scan speed which is typically about 1 minute on 
modern scanners.  
The disadvantage of fan beam DXA is that the photon flux at the edges is lower than the 
middle of the image (due to the inverse square law). As a result, mass calculations may have 
some systematic error, although bone mineral density values have been shown to be 
unaffected.  
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3.3.5.3 Narrow fan beam  
This is designed to overcome some of the limitations of the fan beam geometry. A small fan 
beam radiation (about 4cm wide at the detector) in the long axis is detected by an array of 
detectors. The beam scans the bones in the short patient axis on each individual sweep along 
the long axis of the patient with some beam overlap. Although slightly slower than a fan 
beam scanner (1-2 minutes per scan), the mass results should be more accurate as the 
photon flux has little variability in the area being measured (due to the beam overlap). You 
can see the schematic figure of different beam geometries in the Fig. 4, from mentioned 
website (Royal Adelaide Hospital, 2009). 
 
 
 
Fig. 4. Beam geometry of DXA mechines (from website of Royal Adelaide Hospital 
(Australia) 
3.4 Software 
The reference data of these machines, contain data of BMD tests of almost 5000 Caucasian 
white normal persons; around 20-80 y/o. Any brand of these machines has different 
reference data. It is clear that collecting such huge database, nowadays, seems impossible 
(especially due to cost and financial problems). This makes these method (DXA) and 
machines, unique. It seems impossible that any other method or brand can replace them in 
future, at least in near future. 
Another ability of the software of this machines is, ability to calculate T-score and Z-score 
for patients  (Shepherd &Blake, 2007): 
Measured BMD-Young adultmean BMD
T-score=
Young adultpopulation SD
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Measured BMD-Age-matched mean BMD
Z-score=
Young adultpopulation SD
 
It means after acquisition of absolute BMD of patients by Hardware, the software compute 
the difference between BMD of patient and young adult mean BMD (from reference data in 
the software). Then divide it on young adult population standard deviation, contained in 
the software, the result is T-score. When Z-score is under calculation, the software divides 
the difference between BMD of patient and age-matched mean BMD and divides it on age-
matched population standard deviation. The ability of calculating T—score and Z-score is 
another interesting characteristic of software of these machines. 
As the different brands, have different database, scientists tried to find ways to compare the 
results of deferent machines. Now we suggest some of these methods. 
3.4.1 Providing sBMD 
Genant et al, as inventors of sBMD, explained the methods of providing sBMD  in their 
article, so. 
We can t compare patient information between various DXA scanners, because there isn’t 
any acceptable universal cross-calibration procedure or standard. Although operating on the 
same basic principles, normative databases, are specific and different for each scanner. The 
instruments show differences in scanner design, bone mineral calibration, and analysis 
algorithms. Lunar and Norland scanners rely on daily scanning of standards to provide a 
bone tissue equivalent calibration. Hologic uses an internal calibration system, which 
corrects for short-term instabilities. Also, the software used for analysis of the scans, is 
manufacturer specific (and unique), especially with regard to the edge detection algorithms 
used for separating bone and soft tissue regions. This implementation causes in variations in 
the defined bone area (cm2) and bone mineral content (BMC, g) and density (BMD) of the 
same subject on different systems. Genant et al, study was performed under the auspices of 
the International DXA Standardization Committee to establish appropriate cross-calibration 
parameters. Posteroanterior (PA) lumbar spine measurements of 100 women, ages 20-80 
years (mean 52.6 ± 16, range of BMD = 0.4-1.6 g/cm2) were obtained on a Norland XR26 
Mark II, a Lunar DPX-L, and a Hologic QDR 2000 densitometer using standard procedures 
(pencil beam mode for all three scanners). Area, BMC, and BMD results from the different 
scanners were compared for all patients. In addition, the European spine phantom (ESP) 
and the European spine phantom prototype (ESP prototype), as well as standard phantoms 
from all three manufacturers, were evaluated on the three systems. To reach universal 
scanner calibration, they used the intercept and slope of the patient’s correlations and the 
value of the middle vertebra of the ESP as a reference point in a series of standardization 
formulas, and expressed the results as sBMD (mg/cm2). The correlations of the patients’ 
spinal BMD values were excellent for each of the three scanner pairs. The average absolute 
difference in patient spinal BMD values (L2-L4) between Hologic and Norland was 0.012 
g/cm’ (1.3%); it was 0.113 g/cm’ (11.7%) between Hologic and Lunar and 0.118 g/cm2 
(12.2%) between Norland and Lunar. The phantoms’ regression lines approximated those of 
the patient regression lines, and the phantoms with only one measurement point were very 
close to the patients’ regression lines. After applying the standardization formulas, the 
average absolute variations for the 100 patients were 28 mg/cm2 (2.7%) for 
Hologich/Norland, 23 mg/cm2 (2.2%) for Hologic/Lunar, and 29 mg/cm2 (2.8%) for 
Norland/Lunar. Average BMD results for the patients before correction were 0.972 g/cm2 
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for Hologic, 1.100 g/cm2 for Lunar, and 0.969 g/cm2 for Norland. After correction, sBMD 
results for patients were 1045 mg/cm2 for Hologic, 1047 mg/cm2 for Lunar, and 1043 
mg/cm2 for Norland. The standardization approach as performed in our study provided 
compatibility of DXA results obtained on different scanners. Finally the sBMD for different 
machines calculates as sBMD = 1.0761BMDnorland, sBMDl = 0.9522BMDlunar and sBMDh 
= 1.0755BMDhologic. (Genant et al., 1994). 
3.4.2 Use of NHANES III 
When the reference-data of different machines (the young-adult mean BMD), used for 
defining T-score of patient, the variability within these reference data of different brands, 
substantially impacts osteoporosis prevalence with using this T-score-based approach. 
Binkley et al, emphasize that ideally, all bone mass measurement devices would use the 
same population to define the young-normal mean BMD and SD, a process that cause 
obtaining of similar T-scores with instruments of different manufacturers. Although use of a 
single large sample population to develop a unique normative database for all 
densitometers has been suggested, this process has not been possible. To increase 
coordination between diagnostic classification, the International Committee for Standards in 
Bone Measurement (ICSBM) agreed on a universal reference database for the femur based 
on NHANES III, the only large standardized reference database ever published (Binkley et 
al., 2005). Looker et al., mention that this data were gathered from 14646 men and women 
aged 20 years and older, using dual-energy X-ray absorptiometry,  and included bone 
mineral density (BMD), bone mineral content (BMC) and area of bone scanned in four 
selected regions of interest (ROI) in the proximal femur: femur neck, trochanter, 
intertrochanter and total. These variables are separated by age and sex for non-Hispanic 
whites (NHW), non-Hispanic blacks (NHB) and Mexican Americans (MA). They emphasize 
that the updated data on BMD for the total femur ROI of NHW have been selected as the 
reference database for femur standardization efforts by the International Committee on 
Standards in Bone Measurements (Looker et al., 1998).  The ICSBM published formulae to 
convert measured BMD into standardized BMD (of total femur), thereby allowing use of the 
NHANES III database by other brands’ densitometer. The NHANES III data were acquired 
using Hologic densitometers (Binkley et al., 2005). 
4. General consideration in bone mineral densitometry 
4.1 Recommendation about ROIs that should assess 
Siminoski et al., have some recommendations about ROIs that are under measurement: 
 In the lumbar spine, using a minimum of 2 valid vertebra is recommended (if there is 
problems in L1-L4 vertebrae that cause exclusion one or 2 of them). 
 In the proximal femur, Ward’s area should not be included in the report, as the small 
amount of bone yields measurements of poor accuracy and reproducibility. 
 If either hip or spine is not valid, forearm BMD is recommended. Preferred site is 1/3 
radius, 33% radius or proximal radius. 
 When the final report includes a graph of the patient's BMD, it should be based on the 
same anatomic levels that were used for numeric results; for example if L3 and L4 were 
excluded from spinal analysis because of degenerative objects, the graph should be 
based on the combined value for L1 and L2(Siminoski et al., 2005). 
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4.2 What is the criteria for using other sites for densitometry? Calcaneus an example 
For densitometry we can also use appendicular skeleton. Particularly the calcaneus is an 
excellent site for measurements by a range of techniques. So we use it as an example for 
describing the rules of choosing ROI for bone mineral densitometry. The calcaneus  is easily 
accessible with little overlying soft tissue. It is not a common fracture site but remember that 
in the spinal region, the most susceptible sites for fracture are at T7_ T8 and T11_L1, but we  
measure bone mineral content to L1_L4 because of less overlying soft tissue. 
The remodeling of trabecular bone is more active than cortical bone. It means trabecular 
bone is more active metabolically and more sensitive to metabolic bone changes. Calcaneus 
is made up, almost entirely of trabecular bone and may provide a more sensitive 
measurement site for finding early signs of diseases that affect mostly metablism. A number 
of studies suggested that bone mass of calcaneus may contribute to fracture risk in other 
sites and that its predictive power is not very different than that of  spine and hip.  The 
study by Cummings et al. as cited in Kang and speller; 1999,  confirmed this in  65 years old 
women and over.Interestingly, many early single energy measurements of bone mineral 
were made in the calcaneus, because it is a peripheral site that can be immersed to water. 
The arrival of dual energy techniques changed the focus. Earlier studies validated a highly 
significant correlation between the ashed bone mass of cadaver calcanei and the measured 
BMC values of calcaneus by densitometry (r=0.97). Kang and Speller, describe calcaneus as a 
site with excellent accuracy that it’s  measurements can be made quickly and easily and with 
portable instruments. (Kang & Speller, 1999) 
4.3 Operators, the heart of a BMD center 
Correct positioning among other factors is very important to ensure an optimal scan. 
Simonoski et al., emphasize that correct and consistent positioning and labelling of hip and 
lumbar spine (as the main job of operators), are important when evaluating serial 
assessments (monitoring of patients). It is important to follow manufacturer-specific 
protocols to ensure appropriate comparisons with normative reference data. 
Structural abnormalities and artifacts can significantly influence the results. Independent 
factors, like body weight, may affect BMD results. However, in interpreting the results of a 
scan, first of all,  it must be described whether the scan is valid with regards to positioning, 
artifact, and analysis, or not (Siminoski et al., 2005) 
Fuleihan et al, assessed the effects of the machine, operator and subjects on error of 
measurements of bone density. They explained their technique for this assessment as an 
analysis applied to data from a prospective study of BMD measurements on spine phantoms 
and on pre- and postmenopausal women. Scans performed on the same day or up to 4 
weeks apart with DXA (QDR IOOOW, Hologic). Their model assessed (or suggested) that : 
operators' and subjects' variability  were the most causes of errors in measurements rather 
than machine performance (Fuleihan et al., 1995). Subjects are not changeable or 
controllable, but operators job can be under quality control and its quality develops by time 
(and experience). These machines, are not very extensively distributed, and any machine is 
unique in its way (the data of a second scan of a patients, can be compared to data on the 
same machine that first BMD is performed, only). These make finding expert operators for 
these machines, not very easy. What mentioned above, is the cause that operators are called 
“the heart” of BMD centers. So some-ones believe in this sentence “Never change your 
operators (in BMD departments) and if the change is inevitable, never change them again.” 
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4.4 Material of a standard BMD report 
Shimonoseki et al, recommend that , a standard BMD report should include:  
 Patient identifiers.  
 DXA scanner identifier.  
 BMD results expressed in absolute values (g/cm2; 3 decimal places) and T-score (1 
decimal place) for lumbar spine; proximal femur (total hip, femoral neck, and 
trochanter); and an alternate site (forearm BMD preferred: 1/3 radius, 33% radius or 
proximal radius) if either hip or spine is not valid.  
 A statement about any limitations due to artifacts, if present.  
 The fracture risk category (low, moderate, or high). It must be included major clinical 
factors that modify absolute fracture risk probability (with an indication of the 
corresponding absolute 10-year fracture risk of <10%, 10-20%, or >20%). 
 A statement as to whether the change is statistically significant or not for serial 
measurements. The BMD centre's least significant change for each skeletal site (in 
g/cm2) should be included (Siminoski et al., 2005) 
4.5 Discordance 
Discordance makes difficulties in diagnosis of osteoporosis and management of osteoporotic 
patients. Moayyeri et al, explain, discordance in diagnosis of osteoporosis that is defined as 
presence of different categories of diagnosis based on T-score (osteoporosis, osteopenia, and 
normal) in two skeletal sites of an individual patient. They mansion that discordance has 
been divided into two groups: major and minor . When the different sites results, are close; 
i.e., normal in one site and osteopenic in the other site, or, when  patient is diagnosed as 
osteopenic in one site and osteoporotic in the other site, minor discordance happens. When 
patient diagnosed normal in one site and is osteoporosis in another site, major discordance 
happens. (Moayyeri et al., 2005). In a clinical study, BMD measurements performed at 
lumbar spine both for baseline risk assessment and for monitoring purposes. Leslie et al. 
discuss a difficulty that clinician are confronted with highly discordant measurements and 
at the same time lumbar spine is worse than femoral neck and about how this should be 
integrated into the decision-making process. They discuss about different guideline 
recommendations in this situation. They say under NOF guideline, if t-score in lumbar spine 
is in osteoporotic range without consideration to estimated risk -by special soft-wares-, 
treatment should be recommended. In other national guideline such as those from the UK, 
till a 10 year fracture risk prediction from the femoral neck does not reach the intervention 
threshold, don’t recommend any treatment for patients with osteoporotic lumbar spine. 
Canadian guidelines have attempted to show the issue of site discordance (in femur) by 
recommending use of the minimum T-score, in femur for diagnosis and treatment of 
osteoporosis. However, Leslie et al. suggest that this may systematically overestimates 
fracture risk and does not consider site-specific differences in fractures or the way BMD 
declines with age. They suggest that as lumbar spine and hip measurements are both 
performed for clinical purposes, using a procedure that accurately reflects the contribution 
of each measurement site to fracture risk, is clearly preferred, so they propose a a procedure 
for adjusting FRAX probability, based upon the T-score difference between the lumbar spine 
(LS) and femoral neck (FN). This procedure is termed “offset”. They furmulated following 
rule: “Increase/decrease FRAX estimate for a major fracture by one tenth for each rounded 
T-score difference between LS and FN.” (Leslie et al., 2011) 
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4.6 Pediatric consideration 
4.6.1 Low bone mass in pediatrics 
New investigations show prevalence of low BMD in children is very high and it is higher 
than expected range. Genetic, environmental and iatrogenic factor are 3 most important 
factor that lead to bone disorders in children.   
Bogunovic et al., name causes of pediatric osteoporosis as idiopathic juvenile osteoporosis 
and heritable connective tissue disorders like osteogenesis imperfect and Ehler–Danlos. 
They also name a long list of factors as secondary causes of pediatric osteoporosis that 
include neuromuscular disorders (cerebral palsy and Duchenne muscular dystrophy), 
childhood cancer, endocrine disorders (Turner Syndrome and juvenile diabetes mellitus), 
and inborn errors of metabolism (Gaucher disease) and Chronic diseases like thalassemia. 
Anticonvulsants, glucocorticoids, and various forms of chemotherapy may adversely affect 
normal skeletal maturation (Bogunovic et al., 2009). 
4.6.2 Problems with DXA in pediatric 
Bone mass densitometry by dual X-ray absorptiometry (DEXA) of the lumbar spine and 
femoral  neck is recommended as one of the most reliable and non-invasive technique for 
the assessment of bone mass (Hamidi et al., 2008).  This method is very common around the 
world and many pediatric studies about bone densitometry and body composition have 
been published by using this method. (Van Kuijk, 2010).WHO osteoporosis diagnostic 
criteria should not be applied to children. We can’t use T-score because children have not 
reached PBM, yet. Instead, in children, Z-score must be noticed, that it is a comparison of 
BMD of child to pediatric normative data. If the z- score is below -2 , we can use the term 
‘low bone density for chronologic age” (Daniels et al., 2003). DXA is reliable and accurate for 
adult but in children there is a challenge for it. As it is known, true bone density is a result of 
dividing BMC(g) by volume(cm3). In DXA , BMD is determined by dividing BMC by 2 
dimensional area of a three dimensional objective (bone). By the use of these criteria smaller 
bone appear to have a lower BMD than larger bones.  (Bogunovic et al., 2009). Bone size 
does not change, in adults, over time. On the contrary, bone size changes in growing 
children in 3 dimentions. When we screen children with DXA and follow them over time, 
we actually measure their growth instead of measuring actual changing in BMD.(Van Kuijk, 
2010). It must be remembered that wide variation of height, and bone size in children makes  
interpretation of BMD difficult, especially in short children. Bogunovic et al., mention that 
longitudinal evaluation of a given patient over time is affected by the ever-changing size of 
the growing skeleton and the rates of skeletal growth vary with each bony dimension 
(Bogunovic et al., 2009). All this problems, cause to ask a question: Is it right to use  DXA for 
measuring bone density and fracture risk in children or not? In response we emphasize 
some useful points about DXA. First it has fewer radiation than other methods, that is very 
important in radiology of children, 2) it  is not a fearful (less noisy with no tunnel) method 
for children  densitometry, 3) It is used worldwide and many pediatric studies, have been 
published in the field of bone densitometry and in the field of body composition studies, by 
using DXA method also 4) Studies about the relationship between bone density and 
fractures in healthy children, suggested that bone mass may contribute to fracture risk in 
childhood (Van Kuijk, 2010). So may be the answer is that performing DXA for 
measurement bone density and fracture risk in children, is a helpful method yet. However 
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we should emphasize that bone fragility in children extends beyond single BMD 
measurement, and bone geometry and body size influence it and in the diagnosis of 
osteoporosis, the presence of both a clinically significant fracture history and low bone mass, 
must be noticed (Bogunovic et al., 2009). 
4.6.3 Special consideration of comparison of normal children and children with 
chronic disease, some points in BMD of chronic ill children 
The measurement of BMC (g/cm) and BMD (g/cm2) are not only dependent on the mineral 
density of cortical and spongious bone, but also depend on the bone geometry. Lower BMD 
or BMC in shorter children may not describe a mineral deficiency or mineralization 
disorder, as is often thought, because the smaller bone may show lower BMD because of 
properties of DXA methods (Schonau,1998).  BMD measurement in children is more affected 
by the wide variation of age at onset and progression of puberty. This leads to a wide 
variation in the age at reach of peak bone mass. It is thought the presence of a chronic 
disease, like  juvenile arthritis, cause delay in pubertal onset and development. It has been 
estimated that one-third to one-half of the total mineralization in the lumbar spine in adult 
women is occurred during the 3 years around the onset of puberty.  Therefore, we can t 
compare the BMD of a well-grown 13-year-old girl who is in mid-puberty with that of a 
small pre-pubertal  13-year-old with juvenile arthritis. Rabinovich remembers us that a DXA 
scan is not needed to tell who has the lower BMD. The question then is, is the BMD result in 
this small pre -pubertal girl  normal? (Rabinovich, 2004).  
As van Kuijk suggests, children with chronic disorders or medication, should never be 
compared with age-matched reference (normal) values. They should be compared with 
children with the same maturation status (skeletal age) (Van Kuijk, 2010). 
5. Geometry (Another use of dual x-ray absorptiometry) 
Some important factors such as the shape and structure of bone and the risk of falling, affect 
susceptibility to fracture so BMD alone cannot exactly predict who will have fracture. As 
Gregory and Aspden emphasize, the geometry of the proximal femur is a vital component 
in determining a person’s risk of hip fracture. When a trauma occurs, such as a fall, the 
shape and structure of the femur determines how the forces are passed through the bone 
from the point of impact and whether they surpass the inherent strength of the bone and 
result in a fracture or not. Geometry component is seen in the picture from Gregory and 
Aspden article (Fig. 5.)  
They explained any of these components  
 Hip axis length: The distance from greater trochanter to inner pelvic brim, shown 
between points A and C in Fig. 5 
 Femoral neck axis length (FNAL): 
Femoral neck axis length is the linear distance measured from the base of the greater 
trochanter to the apex of the femoral head. It is illustrated by points B to C in Fig. 5. 
Confusingly, it is also sometimes referred to in the literature as hip axis length. 
 Femoral neck width (FNW):  
The narrowest distance across the femoral neck, often constrained to being perpendicular to 
the neck axis. The distance between points F and G in Fig. 5. 
 Neck-shaft angle: 
Usually defined as the angle between the femoral neck axis and the shaft axis (angle at point 
H in Fig. 5). 
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 Other geometrical measures: In addition to the most common measures of geometry 
discussed above, a number of other measures have also been related to fracture; 
including a thinner femoral shaft cortex , a thinner femoral neck cortex , a smaller calcar 
femoral (a dense, vertically orientated bone present in the posteroemedial region of the 
femoral shaft under the lesser trochanter of the femur) , a narrower trochanteric width  
and smaller inner and outer pelvic diameters. In contrast, an increased femoral head 
diameter has been related to increased bone strength. 
 
 
Fig. 5. Diagram illustrating some of the most common geometrical measurements made 
from the proximal femur (from Gregory and Aspden, 2008). 
Two methods are must commonly used for assessing bone geometry, radiography and dual 
energy X-ray absorptiometry (DXA) (fan beam devices, more provide this service). Each of 
them; has its own advantages and disadvantages. Femoral geometry is important in 
determining both bone strength and fracture risk. The strongest associations with both 
outcomes appear to be a longer (Hip axis length) HAL and larger NSA (Neck-shaft angle) 
(Gregory & Aspden, 2008). 
6. Finite element (An helpful method for better understanding of bone) 
Need to a mathematical tool for solving complex mathematical problems, is answered by 
inventing Finite-element modeling (FEM). It helps to understand patterns of stress, strain, 
deflections, heat transfer, fluid flow, etc., in computer models of organic structures. Ross, 
emphasize that FEM provides a method for addressing a range of questions that are otherwise 
intractable, or very difficult to solve -in vivo or in vitro- and is potentially one of the most 
powerful tools in the methodological tool of vertebrate biomechanics. For example, clarifying 
functional consequences of the remarkable histological and morphological diversity of the 
vertebrae, is one of  the important  aims of  vertebrate biomechanics.  Many of researches on 
various disorders or diseases of the bone, are relied on this structure-function relationship. 
Skeletal health during long term space flight, as well as interpretation of skeletons found in the 
fossil and archeological records, are benefitted from these researches. Ross mentions that form-
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function relationships of the skeleton are therefore of concern to bioengineers, clinicians, 
biological anthropologists, and paleontologists, and FEM provides a method for studying 
them. He also suggests that the availability of increasingly powerful computers at 
progressively more affordable prices has made FEM an accessible tool for biomechanists and 
the wide use of FEM in clinical research is now imitating many basic science researches (Ross, 
2005).  Finite element can be helpful in femoral characteristics finding as helpful as is in spinal 
vertebrae and finding the mechanisms and risk factors for fracture.   
7. Recent progress in bone imaging for osteoporosis research 
Development  in bone imaging techniques have provided tools for analyzing bone structure at 
the macro-, micro- and nano-level. Ito, provided a list of recent progress in bone imaging as  
 High-resolution CT (HR-CT) and high-resolution magnetic resonance (HR-MR). They are 
in vivo quantitative techniques for assessing the microstructure of trabecular bone non-
invasively and non-destructively. Compared with MR imaging, CT-based techniques 
have the advantage of directly visualizing the bone in the axial skeleton, with high spatial 
resolution (of course, disadvantage of delivering a considerable radiation dose remains).  
 Micro-CT (μCT) and Synchrotron μCT (SR-CT). The farmer provides a higher resolution 
of the microstructure and is principally applicable in vitro, has undergone technological 
advances such that it is now able to elucidate the physiological skeletal change 
mechanisms associated with aging and determine the effects of therapeutic intervention 
on the bone microstructure. In particular, synchrotron μCT (SR-CT) provides a more 
detailed view of trabecular structure at the nano-level.  
 DXA-based hip structure analysis (HSA) and CT-based HAS. DXA-based HSA is a 
convenient tool for analyzing biomechanical properties and for assuming cross-
sectional hip geometry based on two-dimensional (2D) data. CT-based HSA provides 
these parameters three-dimensionally in robust relationship with biomechanical 
properties, at the cost of greater radiation exposure and the lengthy time required for 
the analytical procedure.  
The author, suggests that further progress in bone imaging technology is promising to bring 
new aspects of bone structure in relation to bone strength to light, and to establish a means 
for analyzing bone structural properties in the everyday clinical setting (Ito, 2011). 
8. Conclusion 
Tanner in his article reminds us the Bonnick suggestion (noted in the preface of the most 
recent edition of the author’s book on bone densitometry in clinical practice)”. . . as strange as 
it may seem, the technology itself is in danger of becoming so devalued that improvements in 
accessibility and advances in applications may be lost.” (Bonnick SL. as cited in Tanner, 2011 
from book “Bone densitometry in clinical practice: application and interpretation”(current 
clinical practice series). 3rd ed. Totowa, New Jersey:Humana Press; 2010). The future of DXA 
bone density testing is challenged by reimbursement, complicated guidelines, and the 
controversy over the monitoring of treatment. Nevertheless, bone health assessment and 
fracture risk prediction rely on quality bone density measurement using DXA (Tanner, 2011).  
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